Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2000
12/21/2000CA2376933A1 Methods and compositions for control of bone formation via modulation of leptin activity
12/21/2000CA2376889A1 Soluble keratin peptide
12/21/2000CA2376735A1 Recombinant adenoviruses for the sodium/iodide symporter (nis)
12/21/2000CA2376717A1 Human poly(adp-ribose) polymerase 2 materials and methods
12/21/2000CA2376715A1 Aminotetralin derivative for the therapy of cardiovascular diseases
12/21/2000CA2376693A1 Immunological control of .beta.-amyloid levels in vivo
12/21/2000CA2376675A1 Antagonists of bmp and tgf.beta. signalling pathways
12/21/2000CA2376667A1 Gene expression modulated in gastrointestinal inflammation
12/21/2000CA2376630A1 Induction of vascular endothelial growth factor (vegf) by the serine/threonine protein kinase akt
12/21/2000CA2376479A1 Retro-inverso peptides derived from interleukin-6
12/21/2000CA2376474A1 Retro-inverso peptides derived from leukemia inhibitory factor
12/21/2000CA2376467A1 Hyaluronidase from the hirudinaria manillensis, isolation, purification and recombinant method of production
12/21/2000CA2376432A1 Novel protein and dna thereof
12/21/2000CA2376421A1 Identification and molecular characterisation of proteins, expressed in the tick salivary glands
12/21/2000CA2376420A1 Statine-derived tetrapeptide inhibitors of beta-secretase
12/21/2000CA2376394A1 Retro-inverso peptides derived from interleukin-3
12/21/2000CA2376389A1 Cloning and expression of a novel 5-ht4 receptor
12/21/2000CA2376357A1 .mu.o-conopeptides and their use as local anesthetics
12/21/2000CA2375320A1 Dna vaccines for pets or for animals used in sports
12/21/2000CA2374909A1 Human intracellular signaling molecules
12/21/2000CA2374678A1 Diagnosis, prognosis and treatment of cancer related to the barx2 gene
12/21/2000CA2374632A1 Cyclo-imino depsipeptides and their utilization in controlling endoparasites
12/21/2000CA2374000A1 Use of soluble protein molecules expressed by the pancreas and kidney glomerulus
12/21/2000CA2372558A1 Pharmaceutical preparation containing modifications of surfactant protein b (sp-b) and surfactant protein c (sp-c)
12/20/2000EP1061129A1 Infectious retroviruses from a leukemic dog cell line with extensive homologies to murine leukemia viruses
12/20/2000EP1060750A2 Method for treating amyloidosis
12/20/2000EP1060748A1 Remedies for corneal epithelium disturbance
12/20/2000EP1060747A2 Fibrin(ogen) degradation and clot lysis by fibrinolytic metalloproteinase
12/20/2000EP1060746A1 Protein-free preparations
12/20/2000EP1060745A2 A composition and method for treating bacterial infection
12/20/2000EP1060739A1 Slimming cosmetic composition containing L-arginine or a derivative thereof
12/20/2000EP1060261A1 Poly zinc finger proteins with improved linkers
12/20/2000EP1060260A2 Elongation factor-2 kinase (ef-2 kinase) and methods of use therefor
12/20/2000EP1060259A2 Novel means and methods for the preparation and activation of nucleoside and nucleotide based drugs
12/20/2000EP1060254A2 Human proteinase molecules
12/20/2000EP1060251A2 Phosphodiesterase 10
12/20/2000EP1060249A1 Epitope peptides immunogenic against streptococcus pneumoniae
12/20/2000EP1060248A1 Lectomedin materials and methods
12/20/2000EP1060247A1 Compositions containing an ox-40 receptor binding agent or a nucleic acid encoding the same and methods for enhancing antigen-specific immune response
12/20/2000EP1060246A2 Method for selecting ribozymes which are capable of covalently modifying the ribonucleic acids on 2'-oh-groups in trans
12/20/2000EP1060192A2 Glp-2 derivatives with helix-content exceeding 25 %, forming partially structured micellar-like aggregates
12/20/2000EP1060191A1 Derivatives of glp-1 analogs
12/20/2000EP1060190A1 New salt forms of (2e)- 5-amino-5- methylhex-2- enoic acid n-methyl-n-((1r)-1-(n- methyl-n-((1r)-1-(methylcarbamoyl)-2- phenylethyl)carbamoyl)-2- (2-naphtyl)ethyl)amide
12/20/2000EP1060189A1 Derivatives of glycopeptide antibacterial agents
12/20/2000EP1060185A1 Isolated nucleic acid molecules which encode tage molecules, and uses thereof
12/20/2000EP1059941A1 Pharmaceutical compositions and their use
12/20/2000EP1059937A2 Il-12 enhancement of immune responses to t-independent antigens
12/20/2000EP1059934A2 Matrix protein compositions for wound healing
12/20/2000EP1059933A1 Method of increasing bone toughness and stiffness and reducing fractures
12/20/2000EP1059932A1 Method for reducing susceptibility to hiv infection
12/20/2000EP1059931A2 Utilization of cd137 in order to promote the proliferation of peripheral monocytes
12/20/2000EP1059929A2 Isolated stromal cells for use in the treatment of diseases of the central nervous system
12/20/2000EP1059919A1 Small molecules that increase the conversion of food to body weight gain
12/20/2000EP1059913A1 Emulsion preconcentrates containing cyclosporin or a macrolide
12/20/2000EP0877555A4 Method of inhibiting immune system destruction of transplanted viable cells
12/20/2000EP0830371B1 IMIDAZO(1,5a]PYRIDINE DERIVED SERINE PROTEASE INHIBITORS
12/20/2000EP0823848A4 Tissue adhesive using synthetic cross-linking
12/20/2000EP0778733B1 A basic protein composition for killing or inhibiting microbial cells
12/20/2000EP0761682B1 Cyclodepsipeptides
12/20/2000EP0753526B1 Adipocyte differentiation inhibitor peptide and adipocyte differentiation inhibitor containing said peptide as active ingredient
12/20/2000EP0671934B1 Method of treating cell damage or depletion
12/20/2000CN1277634A New tissue-specific calpaines, their production and their use
12/20/2000CN1277633A Mutants of thyroid stimulating hormone and methods based thereon
12/20/2000CN1277632A Natural human antibody
12/20/2000CN1277616A Peptides capable of inhibiting the interaction between presenilins and the beta-amyloid peptide or its precursor
12/20/2000CN1277614A Mammaglobin a secreted mammary-specific breast cancer protein
12/20/2000CN1277556A Application of TNF antagonists as medicaments for treating septic diseases
12/20/2000CN1277550A Modified release multiple-units compositions of non-steroid anti-inflammatory drug sbstances (NSAIDS)
12/20/2000CN1277262A Urokinase zymogen mutant
12/20/2000CN1277208A New angio-auxin derivative protein and its code sequence
12/20/2000CN1277061A Preparation of oral collagen with gradient molecular weight
12/20/2000CN1059705C Composition for introducing nucleic acid complexes into higher eucaryotic cells
12/20/2000CN1059597C Nerve injury recovery preparation
12/19/2000US6162963 Generation of Xenogenetic antibodies
12/19/2000US6162909 Deprotection of RNA
12/19/2000US6162907 Dna and amino acid sequence of derivative of glucagon-like peptide i; antidiabetic agents for treatment of type ii diabetes mellitus
12/19/2000US6162901 Vesicle transport protein
12/19/2000US6162900 Amino acid sequences of polypeptide which transports cadmium, iron(ii), cobalt, manganese, lead, mercury, and zinc; transgenic plants with increased metal uptake for use as nutrient supplements or removing toxic metals from soils
12/19/2000US6162899 Human HNEAA81 receptor
12/19/2000US6162898 Mutant Rev transdominant repressors of HIV replication
12/19/2000US6162897 17q-linked breast and ovarian cancer susceptibility gene
12/19/2000US6162896 Isolated polypeptide encoded by a defined nucleotide sequence; antitumor agents; wound healing agents; immunosuppressants; diagnosis and treatment of immune, reproductive, or central nervous system disorders
12/19/2000US6162828 Cysteine protease inhibitor
12/19/2000US6162800 N-(pyrimidinyl)-aspartic acid analogs as interleukin-1β converting enzyme inhibitors
12/19/2000US6162791 Thiadiazole compounds useful as inhibitors of cysteine activity dependent enzymes
12/19/2000US6162790 Oligopeptides
12/19/2000US6162788 Chlamydia intracellular inclusion bodies in cells
12/19/2000US6162787 Methods for treating arthritis using collagen type II, glucosamine chondroitin sulfate, and compositions
12/19/2000US6162786 Bactericides that inhibit ovomacroglobulin
12/19/2000US6162785 Polypeptide with amino acid sequence
12/19/2000US6162630 Asp1
12/19/2000US6162629 Preparing a serine protease solution; eluting protease from column, freeze drying, filtering and recovering protease
12/19/2000US6162625 Phenylalanyl tRNA synthetase from streptococcus pneumoniae
12/19/2000US6162618 Nucleotide sequence; recombinant production; diagnosis of infections; drug screening; bactericides; bacteriostats; enzyme inhibitors; vaccines
12/19/2000US6162616 Multidrug resistance-associated polypeptide
12/19/2000US6162612 Enzymatic polypeptide; for te detection of enzyme inhibitor which can be used to treat cancer, psoriasis and vascular system defects; anticarcinogenic agents
12/19/2000US6162601 Nucleotide sequence coding mammalian polypeptide; for the diagnosis, prevention, and treatment of developmental, vesicle transportation, tumors and immunnological defects; antitumor agents
12/19/2000US6162461 Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1, VP2 and VP3 or sequences of that virus coding therefor
12/19/2000US6162440 Variant competes with ebna2 protein for cbf1, a cellular dna-binding protein; ebna2 is a transcriptional activator that regulates viral latency gene expression and activates expression of cellular genes; suppressing epstein-barr virus
12/19/2000US6162439 An isolated polypeptides derived from novel lentiviruses for the detection of aids
1 ... 2312 2313 2314 2315 2316 2317 2318 2319 2320 2321 2322 2323 2324 2325 2326 2327 2328 2329 2330 2331 2332 ... 3163